Genomic changes in melanomas

Biochemistry, Genetics and Molecular Biology

1. Germ Cell 85%
2. Germline 85%
3. Ultraviolet Radiation 70%
4. Whole Genome Sequencing 57%
5. Promoter Region 51%
6. MBD4 45%
7. Mutated Genes 45%
8. SF3B1 45%
9. Telomere Homeostasis 28%
10. Gene Mutation 28%
11. Somatic Mutation 25%
12. Pembrolizumab 22%
13. Ipilimumab 22%
14. GNAQ 22%
15. GNA11 22%
16. Droplet Digital Polymerase Chain Reaction 22%
17. Telomere Length 22%
18. Mutational Load 22%
19. Histone Variant 22%
20. Nonsense Mutation 22%
21. Inositol Phosphate 22%
22. ATRX 22%
23. Cyclin Dependent Kinase Inhibitor 2A 22%
24. Genotyping 22%
25. Phosphotransferase 22%
26. Clinical Trial 22%
27. extracellular signal regulated kinase 22%
28. Kinase 22%
29. Pan-cancer 22%
30. Genome-Wide Association Study 22%
31. BAP1 22%
32. Mutagenesis 22%
33. Genomics 17%
34. Chromatin Structure 17%
35. Single-Nucleotide Polymorphism 15%
36. Circulating Tumor DNA 14%
37. Transcription 13%
38. Nucleosome 11%
39. Histone 11%
40. Point Mutation 11%
41. Gene Expression 11%

Medicine and Dentistry

1. Melanoma 100%
2. Uvea Melanoma 45%
3. Tumor 37%
4. Germ Cell 26%
5. Ultraviolet Radiation 26%
6. Promoter Region 26%
7. Diseases 25%
8. In Vitro 22%
9. Next Generation Sequencing 22%
10. Pembrolizumab 22%
11. Ipilimumab 22%
12. Metastatic Melanoma 22%
13. Droplet Digital Polymerase Chain Reaction 22%
14. Cell Free DNA 22%
15. Nonsense Mutation 22%
16. Iris Tumor 22%
17. Circulating Tumor DNA 14%
18. Combination Drug 12%
19. Tumor Mutation Burden 10%